Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression

@article{Fernandes2015EffectsOD,
  title={Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression},
  author={Brisa Fernandes and J. Hodge and J. Pasco and M. Berk and L. Williams},
  journal={Drugs & Aging},
  year={2015},
  volume={33},
  pages={21-25}
}
  • Brisa Fernandes, J. Hodge, +2 authors L. Williams
  • Published 2015
  • Medicine
  • Drugs & Aging
  • Osteoporosis is a chronic skeletal disease marked by microarchitectural deterioration of the bone matrix and depletion of bone mineral density (BMD), with a consequent increased risk for fragility fractures. It has been frequently associated with depression, which is also a chronic and debilitating disorder with high prevalence. Selective serotonin reuptake inhibitors (SSRIs), first-line agents in the pharmacological treatment of mood and anxiety disorders, have also been shown to negatively… CONTINUE READING
    33 Citations
    The underestimation of antidepressants role in risk of fractures: clinical and public health implications
    Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
    • 14
    Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men
    • 4
    Is there a nexus between mental and bone health?
    • 4
    The Selective Serotonin Reuptake Inhibitor Fluoxetine Directly Inhibits Osteoblast Differentiation and Mineralization During Fracture Healing in Mice
    • 29
    Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?
    • 15

    References

    SHOWING 1-10 OF 48 REFERENCES
    Antidepressant medications and osteoporosis.
    • 113
    Do SSRIs play a role in decreasing bone mineral density?
    • 16
    Depression, Selective Serotonin Reuptake Inhibitors, and Osteoporosis
    • 34
    The adverse skeletal effects of selective serotonin reuptake inhibitors.
    • 59
    Depression and Bone Metabolism
    • 37
    Update in serotonin and bone.
    • M. Bliziotes
    • Biology, Medicine
    • The Journal of clinical endocrinology and metabolism
    • 2010
    • 67
    • PDF
    Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.
    • 54
    • PDF
    Selective Serotonin Reuptake Inhibiting Antidepressants Are Associated With an Increased Risk of Nonvertebral Fractures
    • 139
    Effect of selective serotonin reuptake inhibitors on the risk of fracture.
    • 362
    • PDF